Vecprobio Inc.
Doing business as Cirsium Biosciences
- UEI
- VES5VBS3VM25
- CAGE
- 94ZY9
- SAM.gov registration
- Expired
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- cirsiumbio.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $16,304,480 |
| FY2024 | $30,262,956 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Gene therapy using plants | Interior Business Center (DO) | $46,567,436 |
Quick answers
Is Vecprobio Inc. registered in SAM.gov?
Vecprobio Inc.'s SAM.gov registration expired on August 8, 2026.
How much has Vecprobio Inc. received in federal contracts?
Federal contracts obligated $16,304,480 to Vecprobio Inc. in fiscal year 2025 and $46,567,436 in fiscal years 2023 through 2027.
How does Vecprobio Inc. rank among federal contractors?
Vecprobio Inc. ranked #26 in PSC AJ11 and #72 in PSC AJ in FY2025.
What is Vecprobio Inc.'s most recent federal award?
Vecprobio Inc.'s most recent federal contract award is Gene therapy using plants (140D042490002), from Interior Business Center (DO), on September 17, 2024.
On GovTribe
See Vecprobio Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors